ReNTox is developed by Pharma Research Bio, a distinguished South Korean pharmaceutical company. Its products are presented as a lyophilized white powder, containing 100 or 200 units of Clostridium botulinum toxin type A. It is reconstituted with 0.9% saline solution prior to administration. The formulation is free from proteins, albumin, and gelatin, reducing the risk of allergic reactions and ensuring a high safety standard.